Cancer Res Treat.  2017 Apr;49(2):306-312. 10.4143/crt.2017.130.

Prediction of Cancer Incidence and Mortality in Korea, 2017

• Jung KW
• Won YJ
• Oh CM
• Kong HJ
• Lee DH
• Lee KH

• KMID: 2378102
• DOI: http://doi.org/10.4143/crt.2017.130

Abstract

PURPOSE
This study aimed to report on cancer incidence and mortality for the year 2017 in Korea in order to estimate the nation's current cancer burden.
MATERIALS AND METHODS
Cancer incidence data from 1999 to 2014 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2015 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observe age-specific cancer rates against observed years, and then multiplying the projected age-specific rates by the age-specific population. The Joinpoint regression model was used to determine at which year the linear trend changed significantly; we only used data of the latest trend.
RESULTS
A total of 221,143 new cancer cases and 80,268 cancer deaths are expected to occur in Korea in 2017. The most common cancer sites are the colorectum, stomach, lung, thyroid, and breast. These five cancers represent half of the overall burden of cancer in Korea. For mortality, the most common sites are the lung, liver, colorectal, stomach, and pancreas.
CONCLUSION
The incidence rate of all cancers in Korea appears to have decreased mainly because of a decrease in thyroid cancer. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluation of cancer-control programs.

Keyword

Incidence; Mortality; Neoplasms; Forecasting; Korea; 2017

MeSH Terms

Breast
Forecasting
Incidence*
Korea*
Linear Models
Liver
Lung
Mortality*
Pancreas
Stomach
Thyroid Gland
Thyroid Neoplasms

Figure

• 

  Fig. 1. The 10 leading types of estimated new cancer cases and deaths by sex in 2017. (A) Estimated new cases. (B) Estimated deaths.

• 

  Fig. 2. Projected age-specific incidences of major cancers during 2017 in Korea. (A) Male. (B) Female.

• 

  Fig. 3. Projected age-specific mortality rates of major cancers during 2017 in Korea. (A) Male. (B) Female.

Reference

References

1. Statistics Korea [Internet]. Daejeon: Statistics Korea;2016. [cited 2017 Feb 15]. Available from:http://kosis.kr.

2. Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016; 48:436–50.

3. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the national cancer incidence database. Cancer Res Treat. 2005; 37:325–31.

4. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization;2000.

5. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization;1994.

6. Boyle P, Parkin DM. Statistical methods for registries. In : Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Cancer registration: principles and methods. IARC Scientific Publication. No. 95. Lyon: IARC;1991. p. 126–58.

7. National Cancer Institute. Joinpoint regression program, version 4.0 [Internet]. Bethesda, MD: National Cancer Institute;c2015. [cited 2015 Jan 8]. Available from: http://surveillance.cancer.gov/joinpoint/.

8. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine;1960.